GEMOX: Oxaliplatin in Pancreatic Cancer
NCT00261092 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2008-04-15
Summary
Primary objective:
* To evaluate overall response rate (based on RECIST criterion)
Secondary objective:
* To evaluate time to progression, clinical benefit, quality of life and safety
Conditions
- Pancreatic Neoplasms
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Won-Sik Lee, MD · sanofi-avents
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma
NCT01470443 ·Status: UNKNOWN ·Phase: PHASE3
-
Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment
NCT05517239 ·Status: COMPLETED ·Phase: PHASE2
-
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
NCT00256295 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
NCT00004190 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients
NCT00271271 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin
NCT00611962 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
NCT00744640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
NCT00087802 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma
NCT01149122 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer
NCT01459614 ·Status: COMPLETED ·Phase: PHASE2
-
Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma
NCT01389414 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
NCT02534337 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
NCT00504192 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
NCT00075452 ·Status: UNKNOWN ·Phase: PHASE3
-
Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC
NCT06033118 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
NCT01308840 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
NCT00496704 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT00552149 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
NCT00527930 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis
NCT04523402 ·Status: UNKNOWN ·Phase: PHASE2
-
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
NCT07046650 ·Status: RECRUITING ·Phase: PHASE2
-
EXIBIT: Oxaliplatin in Biliary Tract Cancer
NCT00174564 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
NCT00256269 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
NCT00276861 ·Status: TERMINATED ·Phase: PHASE2
-
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
NCT05668884 ·Status: RECRUITING ·Phase: PHASE2